PROPHASE LABS INC. - COMMON STOCK
0.6190
10-1月-25 12:21:21
15 分の遅延
株式
+0.0300
+5.09%
本日の幅
0.5700 - 0.6200
ISIN
N/A
ソース
NASDAQ
-
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
02 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
25 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Unveils Project ZenQ-AI
16 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
10 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 4 2024 20:00:00 提供 Nasdaq GlobeNewswire
-
15 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
08 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
20 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
14 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
30 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
23 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
04 1 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023
09 11 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
02 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
17 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs to Present at The ThinkEquity Conference
12 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
10 8 2023 09:40:00 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023
10 8 2023 07:00:02 提供 Nasdaq GlobeNewswire
-
ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound
03 8 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
02 8 2023 07:00:01 提供 Nasdaq GlobeNewswire